Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, Claus Rödel, Emmanouil Fokas & Franz Rödel. (2022) Advances in nanotechnology-based platforms for survivin-targeted drug discovery. Expert Opinion on Drug Discovery 17:7, pages 733-754.
Read now
Read now
Articles from other publishers (28)
Wei Yang, Jianwei Cao, Hui Cheng, Liang Chen, Meihua Yu, Yu Chen & Xingang Cui. (2023) Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. Bioactive Materials 23, pages 438-470.
Crossref
Crossref
Meng‐Zhen Yu, Nan‐Nan Wang, Jia‐Qing Zhu & Yao‐Xin Lin. (2023)
The clinical progress and challenges of
mRNA
vaccines
. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Yichen Zhong, Shi Du & Yizhou Dong. (2023) mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B 13:4, pages 1348-1357.
Crossref
Crossref
Masoumeh Sharifi-Azad, Marziyeh Fathi, William C. Cho, Abolfazl Barzegari, Hamed Dadashi, Mehdi Dadashpour & Rana Jahanban-Esfahlan. (2022) Recent advances in targeted drug delivery systems for resistant colorectal cancer. Cancer Cell International 22:1.
Crossref
Crossref
Jueshuo Guo, Shijie Ma, Yaping Mai, Ting Gao, Zhihua Song & Jianhong Yang. (2022) Combination of a cationic complexes loaded with mRNA and α-Galactose ceramide enhances antitumor immunity and affects the tumor immune microenvironment. International Immunopharmacology 113, pages 109254.
Crossref
Crossref
Md. Emranul Karim, Sheikh Tanzina Haque, Hamed Al-Busaidi, Athirah Bakhtiar, Kyi Kyi Tha, Mark M. Banaszak Holl & Ezharul Hoque Chowdhury. (2022) Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment. Archives of Pharmacal Research 45:12, pages 865-893.
Crossref
Crossref
Gayathri Ravichandran, Dokkari Nagalaxmi Yadav, Sivasubramanian Murugappan, Sri Amruthaa Sankaranarayanan, Neeraja Revi & Aravind Kumar Rengan. (2022) “Nano effects”: a review on nanoparticle-induced multifarious systemic effects on cancer theranostic applications. Materials Advances 3:22, pages 8001-8011.
Crossref
Crossref
Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen & Wei He. (2022) Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Wanhui Dong, Dezhen Wu, Sheng Xu, Qingming Sun & Xueping Ci. (2022) Construction of a miRNA-mRNA Network Related to Exosomes in Colon Cancer. Disease Markers 2022, pages 1-16.
Crossref
Crossref
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, Rafieh Bagherifar, Hadi Valizadeh, Fatah Kashanchi & Reza Jafari. (2022) Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Randall A. Meyer, Sarah Y. Neshat, Jordan J. Green, Jose Luis Santos & Anthony D. Tuesca. (2022) Targeting strategies for mRNA delivery. Materials Today Advances 14, pages 100240.
Crossref
Crossref
Laura Taina-González & María de la Fuente. (2022) The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA. Pharmaceutics 14:2, pages 460.
Crossref
Crossref
Mingyuan Li, Yuan Li, Shiqin Li, Lin Jia, Haomeng Wang, Meng Li, Jie Deng, Ali Zhu, Liqiao Ma, Weihong Li, Peng Yu & Tao Zhu. (2022) The nano delivery systems and applications of mRNA. European Journal of Medicinal Chemistry 227, pages 113910.
Crossref
Crossref
Androulla N. Miliotou, Ioannis S. Pappas, George Spyroulias, Efthimia Vlachaki, Asterios S. Tsiftsoglou, Ioannis S. Vizirianakis & Lefkothea C. Papadopoulou. (2021) Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders. Molecular Therapy - Nucleic Acids 26, pages 694-710.
Crossref
Crossref
Jingmei Li, Ke Men, Yan Gao, Jieping Wu, Sibei Lei, Yang Yang & Haixia Pan. (2021) Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy. Molecular Pharmaceutics 18:11, pages 4029-4045.
Crossref
Crossref
Francesca Persano, Giuseppe Gigli & Stefano Leporatti. (2021) HALLOYSITE-BASED NANOSYSTEMS FOR BIOMEDICAL APPLICATIONS. Clays and Clay Minerals 69:5, pages 501-521.
Crossref
Crossref
Zheng Chen & Jiheng Liu. (2021) MicroRNA-let-7 Targets HMGA2 to Regulate the Proliferation, Migration, and Invasion of Colon Cancer Cell HCT116. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-9.
Crossref
Crossref
Xueyan Zhang, Anqi Cai, Yan Gao, Yuanfa Zhang, Xingmei Duan & Ke Men. (2021) Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA. Molecular Pharmaceutics 18:9, pages 3387-3400.
Crossref
Crossref
Rui Zhang, Lin Tang, Binyan Zhao, Yaomei Tian, Bailing Zhou, Yandong Mu & Li Yang. (2021) A Peptide-Based Small RNA Delivery System to Suppress Tumor Growth by Remodeling the Tumor Microenvironment. Molecular Pharmaceutics 18:3, pages 1431-1443.
Crossref
Crossref
Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, Emmanouil Fokas & Franz Rödel. (2021) Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions. Cancers 13:4, pages 624.
Crossref
Crossref
Vijay Kumar Singh, Veena Singh & Vishal Tyagi. 2021. Colon Cancer Diagnosis and Therapy. Colon Cancer Diagnosis and Therapy
303
332
.
Chaoyang Meng, Zhe Chen, Gang Li, Thomas Welte & Haifa Shen. (2020) Nanoplatforms for mRNA Therapeutics. Advanced Therapeutics 4:1, pages 2000099.
Crossref
Crossref
Yung-Chieh Chang, Sree Karani Kondapuram, Tsung-Han Yang, Safiulla Basha Syed, Siao Muk Cheng, Tzu-Yu Lin, Yi-Chen Lin, Mohane Selvaraj Coumar, Jang-Yang Chang, Euphemia Leung & Chun Hei Antonio Cheung. (2020) The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. Toxicology and Applied Pharmacology 401, pages 115080.
Crossref
Crossref
Yaping Mai, Jueshuo Guo, Yue Zhao, Shijie Ma, Yanhui Hou & Jianhong Yang. (2020) Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. Cellular Immunology 354, pages 104143.
Crossref
Crossref
Chunhua Yang & Didier Merlin. (2020) Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy. Nanomaterials 10:7, pages 1424.
Crossref
Crossref
Laura Cabeza, Gloria Perazzoli, Cristina Mesas, Cristina Jiménez-Luna, José Prados, Ana Rosa Rama & Consolación Melguizo. (2020) Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents. AAPS PharmSciTech 21:5.
Crossref
Crossref
Xiangping Liang, Dongpei Li, Shuilong Leng & Xiao Zhu. (2020) RNA-based pharmacotherapy for tumors: From bench to clinic and back. Biomedicine & Pharmacotherapy 125, pages 109997.
Crossref
Crossref
Nina Filipczak, Jiayi Pan, Satya Siva Kishan Yalamarty & Vladimir P. Torchilin. (2020) Recent advancements in liposome technology. Advanced Drug Delivery Reviews 156, pages 4-22.
Crossref
Crossref